Skip to content
Disclosery

Yu Fan

Follow

13F filer, CIK 1668029, CENTRAL, HONG KONG, Hong Kong

Yu Fan reported $73,186,158 across 5 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-008426

Period
2025-06-30
Reported value
$73.2M
Holdings
5
Top 10 weight
100%
New
0
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CBLLadded+130,964$2.45M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CGONexited-163,456-$4M
CSTLexited-22,503-$451K
SGMTexited-57,190-$186K
PYXSexited-69,303-$67.9K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0000950123-25-008426, largest first. % of portfolio is the value over $73,186,158, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KMTSKESTRA MED TECHNOLOGIES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,282,519 shares; 2025Q2: 2,282,519 shares 2,282,519$37.8M51.71%0Timeline
CBLLCERIBELL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,222,202 shares; 2025Q1: 1,222,202 shares; 2025Q2: 1,353,166 shares 1,353,166$25.3M34.63%+130,964Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,070,000 shares; 2025Q2: 2,070,000 shares 2,070,000$3.87M5.29%0Timeline
CARGO THERAPEUTICS INC COMCARGO THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 912,000 shares; 2024Q4: 912,000 shares; 2025Q1: 912,000 shares; 2025Q2: 912,000 shares 912,000$3.76M5.13%0
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 789,618 shares; 2024Q4: 789,618 shares; 2025Q1: 789,618 shares; 2025Q2: 789,618 shares 789,618$2.37M3.24%0Timeline

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CGONCG ONCOLOGY INC163,456$4Mshares
CSTLCASTLE BIOSCIENCES INC22,503$451Kshares
SGMTSAGIMET BIOSCIENCES INC57,190$186Kshares
PYXSPYXIS ONCOLOGY INC69,303$67.9Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-25-008426 base2025-08-14acceptance time not in the bulk data set